In vitro stimulation of human lymphocytes by Epstein-Barr virus

1972 ◽  
Vol 5 (2) ◽  
pp. 318-324 ◽  
Author(s):  
Paul Gerber ◽  
Susan J. Lucas
Virology ◽  
1979 ◽  
Vol 95 (1) ◽  
pp. 222-226 ◽  
Author(s):  
Tohru Kamata ◽  
Shigeaki Tanaka ◽  
Shogo Aikawa ◽  
Yorio Hinuma ◽  
Yasushi Watanabe

1977 ◽  
Vol 146 (2) ◽  
pp. 495-508 ◽  
Author(s):  
D A Thorley-Lawson ◽  
L Chess ◽  
J L Strominger

Studies have been performed on in vitro infection by Epstein-Barr virus (EBV) of subpopulations of human lymphocytes. B cells of adult peripheral or fetal cord blood transform with equal efficiency, whether assayed by DNA synthesis induction or by outgrowth of transformed lymphocytes. In contrast, unfractionated adult lymphocytes transform much less efficiently than those from fetal cord. Reconstitution experiments of different cell preparations indicated that this difference was due to a suppression of B-cell proliferation by adult Ig-negative lymphocytes which fetal Ig-negative lymphocytes were unable to perform. Separation of Ig-negative lymphocytes into various subpopulations revealed that the suppression was performed by T cells. Macrophages and null cells play little or no role in suppression. The relevance of this phenomenon to infection and recovery from EBV infection during and after infectious mononucleosis is discussed.


1981 ◽  
Vol 132 (3) ◽  
pp. 323-335
Author(s):  
J.M. Seigneurin ◽  
C. Desgranges ◽  
J.C. Renversez ◽  
M. Baccard ◽  
C. Micouin

1982 ◽  
Vol 67 (1) ◽  
pp. 129-140 ◽  
Author(s):  
L.E. Wallace ◽  
A.B. Rickinson ◽  
M. Rowe ◽  
D.J. Moss ◽  
D.J. Allen ◽  
...  

1991 ◽  
Vol 111 (1) ◽  
pp. 83-86
Author(s):  
V. V. Kulikov ◽  
A. V. Krivonos ◽  
M. E. Krasheninnikov ◽  
O. V. Borisova ◽  
S. L. Kal'nov

Nature ◽  
1977 ◽  
Vol 267 (5606) ◽  
pp. 52-54 ◽  
Author(s):  
ANDERS ROSÉN ◽  
PETER GERGELY ◽  
MIKAEL JONDAL ◽  
GEORGE KLEIN ◽  
SVEN BRITTON

1999 ◽  
Vol 80 (12) ◽  
pp. 3227-3232 ◽  
Author(s):  
Tim Bloss ◽  
Ajamete Kaykas ◽  
Bill Sugden

Alterations were made in the amino terminus and the first two transmembrane-spanning regions of the latent membrane protein-1 (LMP-1) of Epstein–Barr virus. These mutant proteins were tested for their abilities to patch and to stimulate NF-κB activity. A subset of these derivatives retains the wild-type topology of LMP-1 in the plasma membrane, but has lost the ability to patch. Deletion of residues 9–20 of LMP-1, which contain potential SH3-binding motifs, abrogates patching of LMP-1. However, mutation of the prolines within these motifs, which eliminates binding of LMP-1 to SH3 domains in vitro, does not prevent patching by LMP-1. Deletion of the first two transmembrane regions of LMP-1 does prevent it patching. Some of the derivatives of LMP-1 which do not patch do stimulate NF-κB activity. Patching by LMP-1 appears to be a higher-order assemblage of protein that is compatible with the stimulation of NF-κB activity but is not necessary for this signalling.


Sign in / Sign up

Export Citation Format

Share Document